Abstract
Background
Patient preferences are an important topic of study with respect to attention-deficit hyperactivity disorder (ADHD) interventions, as there are multiple treatment choices available, multiple developmental levels to consider, and multiple potential individuals involved in treatment (children, parents, and adults with ADHD). Stated preference methods such as discrete choice experiment (DCE), best-worst scaling (BWS), and other utility value methods such as standard gamble interview (SGI) and time trade-off (TTO) are becoming more common in research addressing preferences for ADHD treatments. A synthesis of this research may facilitate improved patient-centered and family-centered treatment for ADHD.
Objective
The purpose of this review was to synthesize reports across existing DCE, BWS, TTO, and SGI studies to assess which aspects of ADHD treatment are most studied as well as most preferred and influential in treatment decisions.
Data Sources
MEDLINE, PsycINFO.
Study Selection
A total of 41 studies referring to preferences for ADHD treatment were identified through the initial search and contact with researchers. Of these, 13 reported ADHD treatment preference data from a study using DCE, BWS, or SGI methods. No TTO studies were identified that met inclusion criteria.
Results
Methods and designs varied considerably across studies. Relatively few studies focused on preferences among children, adolescents, and adults compared with those that focused on the preferences of parents of children with ADHD. The majority of studies focused primarily on medication treatments, with many fewer focused on psychosocial treatments. Some studies indicated that parents of children with ADHD prefer to avoid stimulant medications in favor of behavioral or psychosocial interventions. Others report that parents see medication as a preferred treatment. Treatment outcome is a particularly salient attribute for treatment decisions for many informants.
Conclusions
Potential outcomes of various treatments play a proximal role in patients’ and families’ decisions for ADHD treatment. Because the majority of studies focus on medication treatments for children with ADHD, more research is necessary to understand preferences related to behavioral and other psychosocial treatments both as stand-alone interventions and used in combination with medication. Additional research is also needed to assess the treatment preferences of adults with ADHD. In general, DCE, BWS, and SGI methods allow measurement of patient preferences in a manner that approximates the uncertainty and trade-offs inherent in real-world treatment decision making and provides valuable information to inform patient-centered and family-centered treatment.
Similar content being viewed by others
References
Barkley RA. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002;63(Suppl 12):10–5.
Biederman J, Petty CR, Evans M, Small J, Faraone SV. How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res. 2010;177(3):299–304.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington: American Psychiatric Publishing Inc.; 2013.
Daley D, Van der Oord S, Ferrin M, Danckaerts M, Doepfner M, Cortese S, et al. Behavioral interventions in attention-deficit/hyperactivity disorder: A meta-analysis of randomized controlled trials across multiple outcome domains. J Am Acad Child Adolesc Psychiatry. 2014;53(8):835.e5–847.e5.
Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–22.
Conners CK. Forty years of methylphenidate treatment in attention-deficit/hyperactivity disorder. J Atten Disord. 2002;6(Supp1):S30.
Evans SW, Owens JS, Bunford N. Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol. 2014;43(4):527–51.
Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, et al. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(5):456–63.
Adler LA, Spencer T, Brown TE, Holdnack J, Saylor K, Schuh K, et al. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. J Clin Psychopharmacol. 2009;29(1):44–50.
Marchant BK, Reimherr FW, Halls C, Williams ED, Strong RE, Kondo D, et al. Long-term open-label response to atomoxetine in adult ADHD: influence of sex, emotional dysregulation, and double-blind response to atomoxetine. ADHD Attent Deficit Hyperact Disord. 2011;3(3):237–44.
Tanaka Y, Rohde LA, Jin L, Feldman PD, Upadhyaya HP. A meta-analysis of the consistency of atomoxetine treatment effects in pediatric patients with attention-deficit/hyperactivity disorder from 15 clinical trials across four geographic regions. J Child Adolesc Psychopharmacol. 2013;23(4):262–70.
Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Therapy. 2005;43(7):831–42.
Zylowska L, Ackerman DL, Yang MH, Futrell JL, Horton NL, Hale TS, et al. Mindfulness meditation training in adults and adolescents with ADHD: a feasibility study. J Atten Disord. 2008;11(6):737–46.
Marcus SC, Wan GJ, Kemner JE, Olfson M. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2005;159(6):572–8.
Chronis AM, Chacko A, Fabiano GA, Wymbs BT, Pelham WE Jr. Enhancements to the behavioral parent training paradigm for families of children with ADHD: review and future directions. Clin Child Fam Psychol Rev. 2004;7(1):1–27.
Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921. doi:10.1097/chi.0b013e318054e724.
Vallerand IA, Kalenchuk AL, McLennan JD. Behavioural treatment recommendations in clinical practice guidelines for attention-deficit/hyperactivity disorder: a scoping review. Child Adolesc Ment Health. 2014;19(4):251–8.
Kendall T, Taylor E, Perez A, Taylor C. Guidelines: diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance. BMJ. 2008;337(7672):751–3.
Eichner JM, Johnson BH. Patient- and family-centered care and the pediatrician’s role. Pediatrics. 2012;129(2):394–404. doi:10.1542/peds.2011-3084.
Bussing R, Zima BT, Gary FA, Garvan CW. Barriers to detection, help-seeking, and service use for children with ADHD symptoms. J Behav Health Serv Res. 2003;30(2):176–89.
DosReis S, Mychailyszyn MP, Evans-Lacko SE, Beltran A, Riley AW, Myers MA. The meaning of attention-deficit/hyperactivity disorder medication and parents’ initiation and continuity of treatment for their child. J Child Adolesc Psychopharmacol. 2009;19(4):377–83.
Bussing R, Koro-Ljungberg M, Noguchi K, Mason D, Mayerson G, Garvan CW. Willingness to use ADHD treatments: a mixed methods study of perceptions by adolescents, parents, health professionals and teachers. Soc Sci Med. 2012;74(1):92–100.
Charach A, Volpe T, Boydell KM, Gearing RE. A theoretical approach to medication adherence for children and youth with psychiatric disorders. Harv Rev Psychiatry. 2008;16(2):126–35.
Coletti DJ, Pappadopulos E, Katsiotas NJ, Berest A, Jensen PS, Kafantaris V. Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2012;22(3):226–37.
Davis CC, Claudius M, Palinkas LA, Wong JB, Leslie LK. Putting families in the center: family perspectives on decision making and ADHD and implications for ADHD care. J Atten Disord. 2012;16(8):675–84. doi:10.1177/1087054711413077.
Fiks AG, Mayne S, DeBartolo E, Power TJ, Guevara JP. Parental preferences and goals regarding ADHD treatment. Pediatrics. 2013;132(4):692–702. doi:10.1542/peds.2013-0152.
Fiks AG, Mayne S, Hughes CC, DeBartolo E, Behrens C, Guevara JP, et al. Development of an instrument to measure parents’ preferences and goals for the treatment of attention deficit-hyperactivity disorder. Acad Pediatr. 2012;12(5):445–55.
Ryan M, Scott D, Reeves C, Bate A, van Teijlingen E. Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess. 2001;5(5):186. doi:10.3310/hta5050.
Bleichrodt H, Johannesson M. Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs. J Health Econ. 1997;16(2):155–75.
Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, et al. Conjoint analysis applications in health-a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health (Wiley-Blackwell). 2011;14(4):403–13.
Flynn TN, Louviere JJ. Using best-worst scaling choice experiments to measure public perceptions and preferences for healthcare reform in Australia. Patient. 2010;3(4):275–83.
Johnson FR, Lancsar E, Marshall D, Kilambi V, Mühlbacher A, Regier DA, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health. 2013;16(1):3–13.
Flynn TN. Valuing citizen and patient preferences in health: recent developments in three types of best-worst scaling. Expert Rev Pharmacoecon Outcomes Res. 2010;10(3):259–67. doi:10.1586/erp.10.29.
Van Brunt K, Matza LS, Classi PM, Johnston JA. Preferences related to attention-deficit/hyperactivity disorder and its treatment. Patient Prefer Adher. 2011;5:33.
Cooper H, Hedges LV. Research synthesis as a scientific enterprise. In: Cooper H, Hedges LV, editors. The handbook of research synthesis. New York: Russell Sage Foundation; 1994. p. 3–28.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.
Wymbs F, Cunningham C, Chen Y, Rimas H, Deal K, Waschbusch DA, et al. Examining parents’ preferences for group versus individual parent training programs versus a minimal information alternative for children with ADHD symptoms using a discrete choice conjoint experiment. J Clin Child Adolesc Psychol (in press).
Ross M, Bridges JFP, Ng X, Wagner L, Frosch E, Reeves G, dosReis S. A best-worst scaling experiment to prioritize caregiver concerns about attention-deficit/hyperactivity disorder (ADHD) medication for children. Psychiatr Serv. 2014. doi:10.1176/appi.ps.201300525.
Lloyd A, Hodgkins P, Dewilde S, Sasané R, Falconer S, Sonuga Barke E. Methylphenidate delivery mechanisms for the treatment of children with attention deficit hyperactivity disorder: heterogeneity in parent preferences. Int J Technol Assess Health Care. 2011;27(03):215–23.
Secnik K, Matza LS, Cottrell S, Edgell E, Tilden D, Mannix S. Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United Kingdom. Med Decis Mak. 2005;25(1):56–70.
Fegert JM, Slawik L, Wermelskirchen D, Nübling M, Mühlbacher A. Assessment of parents’ preferences for the treatment of school-age children with ADHD: a discrete choice experiment. Expert Rev Pharmacoecon Outcomes Res. 2011;11(3):245–52.
Muhlbacher AC, Nübling M. Analysis of patients’ preferences: direct assessment and discrete-choice experiment in therapy of adults with attention-deficit hyperactivity disorder. Patient. 2010;3(4):285–94.
Nafees B, Setyawan J, Lloyd A, Ali S, Hearn S, Sasane R, et al. Parent preferences regarding stimulant therapies for ADHD: a comparison across six European countries. Eur Child Adolesc Psychiatry. 2014;23(12):1189–2000.
dosReis S, Ng X, Frosch E, Reeves G, Cunningham C, Bridges JF. Using best-worst scaling to measure caregiver preferences for managing their child’s ADHD––a pilot study. Patient. 2014. doi:10.1007/s40271-014-0098-4TI.
Wymbs FA. Examining parents’ preferences for children’s mental health services using conjoint analysis. Rep Emot Behav Disord Youth. 2011;11(3):74–8.
Waschbusch DA, Cunningham CE, Pelham WE, Rimas HL, Greiner AR, Gnagy EM, et al. A discrete choice conjoint experiment to evaluate parent preferences for treatment of young, medication naive children with ADHD. J Clin Child Adolesc Psychol. 2011;40(4):546–61. doi:10.1080/15374416.2011.581617.
Glenngård AH, Hjelmgren J, Thomsen PH, Tvedten T. Patient preferences and willingness-to-pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway. Nordic J Psychiatry. 2013;67(5):351–9.
Matza LS, Secnik K, Rentz AM, Mannix S, Sallee FR, Gilbert D, et al. Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report. Qual Life Res. 2005;14(3):735–47. doi:10.2307/4038822.
Mühlbacher AC, Rudolph I, Lincke HJ, Nübling M. Preferences for treatment of attention-deficit/hyperactivity disorder (ADHD): a discrete choice experiment. BMC Health Serv Res. 2009;9:149.
Sawtooth Software I. ACBC technical paper (Sawtooth Software technical paper series). 2009.
Shah AK, Oppenheimer DM. Heuristics made easy: An effort-reduction framework. Psychol Bull. 2008;134(2):207–22. doi:10.1037/0033-2909.134.2.207.
Cunningham CE, Deal K, Chen Y. Adaptive choice-based conjoint analysis: a new patient-centered approach to the assessment of health service preferences. Patient. 2010;3(4):257–73.
Orme BK. Getting started with conjoint analysis: strategies for product design and pricing research. Chicago (IL): Research Publishers, LLC.; 2006.
Cunningham C, Deal K, Rimas H, Buchanan D, Gold M, Sdao-Jarvie K, et al. Modeling the information preferences of parents of children with mental health problems: a discrete choice conjoint experiment. J Abnorm Child Psychol. 2008;36(7):1123–38. doi:10.1007/s10802-008-9238-4.
Deal K. Segmenting patients and physicians using preferences from discrete choice experiments. Patient. 2014;7(1):5–21.
Cunningham C, Chen Y, Deal K, Rimas H, McGrath P, Reid G, et al. The interim service preferences of parents waiting for children’s mental health treatment: a discrete choice conjoint experiment. J Abnorm Child Psychol. 2013;41(6):865–77. doi:10.1007/s10802-013-9728-x.
Molina BSG, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry. 2009;48(5):484–500. doi:10.1097/CHI.0b013e31819c23d0.
Montoya A, Colom F, Ferrin M. Is psychoeducation for parents and teachers of children and adolescents with ADHD efficacious? A systematic literature review. Eur Psychiatry. 2011;26(3):166–75. doi:10.1016/j.eurpsy.2010.10.005.
Rollnick S, Miller WR. What is motivational interviewing? Behav Cogn Psychother. 1995;23(4):325–34.
De Groot I, Otten W, Dijs-Elsinga J, Smeets H, Kievit J, Marang-Van De Mheen P. Choosing between hospitals: the influence of the experiences of other patients. Med Decis Mak. 2012;32(6):764–78.
Godin G, Kok G. The theory of planned behavior: a review of its applications to health-related behaviors. Am J Health Promot. 1996;11(2):87–98.
Macinko J, Starfield B, Shi L. The contribution of primary care systems to health outcomes within Organization for Economic Cooperation and Development (OECD) countries, 1970–1998. Health Serv Res. 2003;38(3):831–65.
Ungar WJ. Challenges in health state valuation in paediatric economic evaluation. Pharmacoeconomics. 2011;29(8):641–52.
Prosser LA, Hammitt JK, Keren R. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children. Pharmacoeconomics. 2007;25(9):713–26.
Cunningham CE, Vaillancourt T, Cunningham LJ, Chen Y, Ratcliffe J. Modeling the bullying prevention program design recommendations of students from grades five to eight: a discrete choice conjoint experiment. Aggress Behav. 2011;37(6):521–37. doi:10.1002/ab.20408.
Lloyd A, Dewilde S, Yuen C, Price M, Annemans L, Coghill D. The perceived benefits of dosing schedules for children with ADHD [poster]. In: 7th Annual European Congress of ISPOR, Oct 24–26. Germany: Hamburg; 2004.
Acknowledgments
Dr. Gregory Fabiano receives funding through grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development; the Administration for Children and Families Office of Planning, Research, and Evaluation; the Department of Education; and the Institute of Education Sciences. Dr. Fabiano has also received consulting fees from Health and Wellness Partners related to school-based interventions for ADHD and he receives royalties from Guilford Publications. Dr. Charles Cunningham has been the recipient of workshop fees and publication royalties for the Community Parent Education (COPE) Program, which has been used as a psychosocial intervention for parents of children with ADHD. Dr. Cunningham’s participation was supported by the Jack Laidlaw Chair in Patient-Centered Health Care, Faculty of Health Sciences, Michael G. DeGroote School of Medicine, McMaster University.
Dr. Nicole Schatz, Dr. Susan dosReis, Dr. Daniel Waschbusch, Stephanie Jerome, Kellina Lupas, and Karen Morris report no conflicts of interest.
Author Contributions
Dr. Nicole Schatz served as the lead author for this manuscript, conducted the initial literature search, and is the guarantor for the overall content. Drs. Schatz, Fabiano, Cunningham, dosReis, and Waschbusch contributed to the formulation of the research questions, development of the coding manual used to extract data, and identification of papers for inclusion in the review. Dr. Schatz, Dr. Fabiano, Stephanie Jerome, Kellina Lupas, and Karen Morris, were responsible for reviewing papers and applying the coding manual to extract data. Dr. Schatz drafted the manuscript, and all authors were involved in providing input on the interpretation of the data and the overall organization and conceptualization of the manuscript. All authors reviewed and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Appendix: Search Strategy
Appendix: Search Strategy
Database: MEDLINE via Ovid
Date conducted: 24 October 2014
Terms:
-
1.
Attention Deficit Disorder with Hyperactivity (Explode to include all associated terms)
-
2.
Patient Preferences
-
3.
Stated preferences
-
4.
Discrete Choice
-
5.
Conjoint Analysis
-
6.
Best worst
-
7.
Maximum difference
-
8.
Standard gamble
-
9.
Utility values
-
10.
Time trade-off
-
11.
2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10
-
12.
1 and 11
Rights and permissions
About this article
Cite this article
Schatz, N.K., Fabiano, G.A., Cunningham, C.E. et al. Systematic Review of Patients’ and Parents’ Preferences for ADHD Treatment Options and Processes of Care. Patient 8, 483–497 (2015). https://doi.org/10.1007/s40271-015-0112-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40271-015-0112-5